Trial Outcomes & Findings for Mobile Coaching to Improve HPV Vaccine Delivery (NCT NCT05105711)

NCT ID: NCT05105711

Last Updated: 2022-07-25

Results Overview

The change in providers' mean composite score on a 5-item index of self-reported use of HPV vaccine communication practices with scores ranging from 5-25 (5 indicating the lowest quality score to 25 indicating the highest quality score).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

21 participants

Primary outcome timeframe

Baseline, 12 weeks

Results posted on

2022-07-25

Participant Flow

Providers who treat adolescent patients in participating Kaiser Permanente Washington primary care clinics in the Puget Sound and Spokane region. 21 participants consented, with 19 completing the study and 2 not completing the study.

Providers were eligible and worked in clinics that agreed to participate in the study.

Participant milestones

Participant milestones
Measure
Primary Care Providers
Providers who treat 11-12 year old adolescent patients in participating Kaiser Permanente Washington pediatric and family medicine practices. QI coaching intervention: The intervention consists of two main components: a webinar communication workshop and use of the Checkup Coach mobile app. The Checkup Coach intervention begins with a brief (\<1 hour), communication training workshop that reviews evidence on HPV vaccination, models guideline-consistent recommendations, trains providers to address parent concerns, and facilitates discussion of shared goals for improving. Next, providers are invited to download and use the Checkup coach mobile app at their discretion for the 12-week study period. Providers complete in-app self-assessments and receive tailored feedback about their HPV vaccine recommendation quality, progress toward improving recommendation practices, a dashboard of aggregate HPV vaccination coverage for patients in their clinic, and tips for addressing parents' concerns about HPV vaccination every time they use the app.
Overall Study
STARTED
21
Overall Study
COMPLETED
19
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Only participants who completed all parts of the intervention and follow-up were included in analyses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Primary Care Providers
n=19 Participants
Providers who treat 11-12 year old adolescent patients in participating Kaiser Permanente Washington pediatric and family medicine practices. QI coaching intervention: The intervention consists of two main components: a webinar communication workshop and use of the Checkup Coach mobile app. The Checkup Coach intervention begins with a brief (\<1 hour), communication training workshop that reviews evidence on HPV vaccination, models guideline-consistent recommendations, trains providers to address parent concerns, and facilitates discussion of shared goals for improving. Next, providers are invited to download and use the Checkup coach mobile app at their discretion for the 12-week study period. Providers complete in-app self-assessments and receive tailored feedback about their HPV vaccine recommendation quality, progress toward improving recommendation practices, a dashboard of aggregate HPV vaccination coverage for patients in their clinic, and tips for addressing parents' concerns about HPV vaccination every time they use the app.
Age, Customized
>18 years
19 Participants
n=5 Participants
Age, Customized
<18 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
17 Participants
n=5 Participants
Sex: Female, Male
Male
2 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
5 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
Race (NIH/OMB)
White
5 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
4 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants
n=5 Participants
Region of Enrollment
United States
19 participants
n=5 Participants
Mean recommendation quality score
23.4 units on a scale
n=5 Participants • Only participants who completed all parts of the intervention and follow-up were included in analyses

PRIMARY outcome

Timeframe: Baseline, 12 weeks

Population: Primary care providers who participated in the Checkup Coach QI workshop and who completed data collection at all three time points

The change in providers' mean composite score on a 5-item index of self-reported use of HPV vaccine communication practices with scores ranging from 5-25 (5 indicating the lowest quality score to 25 indicating the highest quality score).

Outcome measures

Outcome measures
Measure
Primary Care Providers
n=19 Participants
Providers who treat 11-12 year old adolescent patients in participating Kaiser Permanente Washington pediatric and family medicine practices. QI coaching intervention: The intervention consists of two main components: a webinar communication workshop and use of the Checkup Coach mobile app. The Checkup Coach intervention begins with a brief (\<1 hour), communication training workshop that reviews evidence on HPV vaccination, models guideline-consistent recommendations, trains providers to address parent concerns, and facilitates discussion of shared goals for improving. Next, providers are invited to download and use the Checkup coach mobile app at their discretion for the 12-week study period. Providers complete in-app self-assessments and receive tailored feedback about their HPV vaccine recommendation quality, progress toward improving recommendation practices, a dashboard of aggregate HPV vaccination coverage for patients in their clinic, and tips for addressing parents' concerns about HPV vaccination every time they use the app.
Change in HPV Vaccine Recommendation Quality Score
Baseline
23.4 score
Interval 18.0 to 25.0
Change in HPV Vaccine Recommendation Quality Score
Follow-up
24.2 score
Interval 17.0 to 25.0

Adverse Events

Experimental: Primary Care Providers

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Melissa Gilkey, PhD

University of North Carolina at Chapel Hill

Phone: 919-966-8650

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place